| GCA | Goblet Cell Adenocarcinoma |
| AGCA | Appendiceal Goblet Cell Adenocarcinoma |
| GCC | goblet cell carcinoid |
| GCT | goblet cell tumor |
| MiNEN | mixed neuroendocrine-nonneuroendocrine neoplasm |
| MANEC | mixed adenoneuroendocrine carcinoma |
| FOLFOX | fluorouracil, leucovorin calcium (folinic acid)and oxaliplatin |
| FOLFIRI | fluorouracil, leucovorin calcium (folinic acid) and irinotecan |
| WHO | World Health Organization |
| AJCC | American Joint Committee on Cancer |
| CRS | Cytoreductive Surgery |
| HIPEC | hyperthermic intraperitoneal chemotherapy |
| NET | Neuroendocrine Tumor |
| mNET | midgut Neuroendocrine tumors |
| CEA | Carcinoembryonic antigen |
| COPD | chronic obstructive pulmonary disease |
| FEV | Forced Expiratory Volume |
| IT | inspiratory time |
| CT | computed Tomography |
| HP | histopathology |
| IHC | Immunohistochemistry |
| OS | overall survival |
| CSS | cancer specific survival |
| PFS | progression free survival |
| NCDB | National Cancer Database |
| ICD-O | International Classification of Diseases for Oncology |
| SEER | Surveillance, Epidemiology, and End Results |
| AC | appendiceal carcinoma |
| a- | appendix |
| A- | appendectomy |
| NR | not reach |
| RHC | right hemicolectomy |
| MS | metastasectomy |
| PS | palleative surgery |
| AC | adjuvant chemotherapy |
| PC | palleative chemotherapy |
| SC | Supportive care |
| ICT | intraperitoneal chemotherapy |
| BSO | bilateral salpingo-oophorectomy |
| SCLC r | Small-cell-lung-cancer regimen |
| CRC r | Colorectal cancer regimen |
| NET r | Neuroendocrine Tumor regimen |
| OC r | ovarian cancer regimen |
| MOR | multiorgan resection |
| LD | localized disease, |
| PS | peritoneal spread |
| EID | extensive intraperitoneal disease |
| PCI | peritoneal carcinomatosis index |
| ENETS | European Neuroendocrine Tumor Society |
| ASCRS | American Society of Colon and Rectal Surgeons |
| NANETS | North American Neuroendocrine Tumor Society |
| NCCN | National Comprehensive Cancer Network |
| ESMO | European Society for Medical Oncology |